PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein , Kiel, Germany.\', \'Physiologisches Institut, Abteilung für Vegetative und Klinische Physiologie, Eberhard Karls University of Tübingen , Tübingen, Germany.\', \'Department of Dermatology and Allergology, School of Medicine, Technical University of Munich , München, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/15384101.2020.1859197
?:doi
?:hasPublicationType
?:journal
  • Cell cycle (Georgetown, Tex.)
is ?:pmid of
?:pmid
?:pmid
  • 33305655
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all